首页|动脉粥样硬化心血管疾病超高危患者的血脂达标率及影响因素

动脉粥样硬化心血管疾病超高危患者的血脂达标率及影响因素

扫码查看
目的 评价动脉粥样硬化性心血管疾病(ASCVD)超高危患者的血脂达标率及影响因素。方法 选取2020年1月至12月于内蒙古自治区人民医院住院的ASCVD超高危患者为研究对象,通过临床合理用药监测系统(PASS)临床药师管理系统收集患者资料。纳入指标包括患者入院的实验室数据,以及出院后3周至6个月内复查的实验室数据,包括低密度脂蛋白胆固醇(LDL-C)、三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)。对收集到的数据采用x2检验比较血脂达标组和未达标组患者基线资料;采用单因素、多因素Logistic回归分析对ASCVD超高危患者血脂达标的影响因素进行分析。结果 本研究纳入ASCVD超高危患者214例,经降血脂药物治疗41例达标,达标率19。2%(41/214)。对比血脂达标组和血脂未达标组的基线资料,结果显示他汀类药物强度、心肌梗死(MI)史、经皮冠状动脉介入治疗(PCI)史,差异有统计学意义(P<0。05);单因素Logistic回归分析结果显示,心肌梗死史[OR(95%CI):2。242(1。101,4。566)]、PCI史[OR(95%CI):2。178(1。043,4。546)]和高强度他汀类药物[OR(95%CI):3。361(1。509,7。483)]的使用是患者血脂达标的影响因素(P<0。05);多因素Logistic回归分析显示,高强度他汀类药物[OR(95%CI):2。805(1。211,6。497)]的使用是患者血脂达标的影响因素(P<0。05)。结论 ASCVD超高危人群的血脂达标率较低,高强度他汀类药物可提高该患者人群的血脂达标比例。
Lipid compliance rate and influencing factors of ultra-high-risk patients with atherosclerotic cardiovascu-lar diseases
Objective lo evaluate the lipid compliance rate and influencing factors of ultra-high-risk patients with atherosclerotic cardiovascular disease(ASCVD).Methods Ultra-high-risk patients with ASCVD who were hospitalized in the Inner Mongolia Autonomous Region People's Hospital from January 2020 to December 2020 were selected as study subjects,and patient datas were collected through the PASS clinical pharmacist management system.The included indicators included laboratory data at the time of patient's admission to the hospital and at the time of review within 3 weeks to 6 months after discharge,including low-density lipoprotein cholesterol(LDL-C),triglycerides(TG),total cholesterol(TC),and high-density lipoprotein cholesterol(HDL-C).For the collected data,the chi-square tests were used to compare the baseline information of patients in the lipid-compliance group and the non-compliance group,and univariate and multivariate logistic regression analyses were conducted to explore the factors affecting lipid attainment in ultra-high-risk patients with ASCVD.Results A total of 214 patients with ultra-high risk of ASCVD were included in this study,and 41 of them achieved the target lipid levels after treatment with lipid-lowering drugs,with an attainment rate of 19.2%(41/214).For the baseline data of the lipid-compliance group and the lipid-non-compliance group of patients with different clinical characteristics,the results showed that there were significant differences in statin intensity,history of myocardial infarction(MI),and history of percutaneous coronary intervention(PCI),and the differences were statistically significant(P<0.05).The results of the univariate logistic regression analysis showed that the history of MI[OR(95%CI):2.242(1.101,4.566)],history of PCI[OR(95%CI):2.178(1.043,4.546)]and use of high-intensity statins[OR(95%CI):3.361(1.509,7.483)]were the influencing factors for patients'lipid attainment(P<0.05).And multifactorial logistic regression analysis showed that high-intensity statin[OR(95%CI):2.805(1.211,6.497)]use was an influential factor in patients'lipid compliance(P<0.05).Conclusion The lipid compliance rate among the ultra-high-risk ASCVD patients is relatively low,and high-intensity statin therapy can significantly improve their lipid attainment rate.

AtherosclerosisHypolipidemic agentsHyperlipidemiaCholesterol,LDLRoot cause analysis

郭力文、张勇、乌雅罕、张春霞、侯斯琦

展开 >

内蒙古医科大学药学院,内蒙古自治区呼和浩特 010050

内蒙古自治区人民医院药学处,内蒙古自治区呼和浩特 010000

内蒙古科技大学包头医学院第一附属医院临床药学室,内蒙古自治区包头 014010

内蒙古科技大学包头医学院药学院,内蒙古自治区包头 014000

展开 >

动脉粥样硬化 降血脂药 高脂血症 胆固醇,LDL 影响因素分析

内蒙古自治区人民医院院内基金

2020YN15

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(7)